Month: April 2019

Global Parkinson’s Therapeutic Market Outlook

Articles, Business Consultant, Pharma Consultant

Parkinson’s Disease (PD) is a chronic and progressive movement disorder which primarily affects dopamine-producing...

Read More

Can commoners afford to spend million dollars on GENE Therapy?

Articles, Business Consultant, Chimeric Antigen Receptor (CAR) T-cell Therapy, DelveInsight's Drug Report, Pharma Consultant

Each country has a unique system, politics, and economy. Different policies are designed to suit people of different countries. Same goes...

Read More

World Haemophilia Day

Business Consultant, Pharma Consultant

Each Year 17th April is recognized as World Haemophilia Day. Haemophilia affects 1 in 12,000 people every year. The Cure does exist. This...

Read More

Beta Interferons prolongs life in Multiple Sclerosis

Articles

Multiple Sclerosis is an unpredictable, autoimmune disease that affects the central nervous system, disrupting the transfer of information...

Read More

New Osteoporosis Drug promises to rebuild Bone

Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Pharma Consultant

Osteoporosis is a bone disease that makes bones weak and brittle. Osteoporosis, as the word says itself “porous bones”. As we age, bone...

Read More

Gene Therapy in Oncology: Innovation to Commercialization

Articles

Gene Therapy is a way to introduce a normal working gene in the place of a mutated one which might result in some kinds of abnormalities....

Read More
Close